Remember to assess the 'whole' patient: a further immune-related adverse event of programmed cell death 1 checkpoint inhibition. Hunter HJA. Br J Dermatol 2020;182:276-277.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hunter HJA. Remember to assess the 'whole' patient: a further immune-related adverse event of programmed cell death 1 checkpoint inhibition. Br J Dermatol 2020;182:276-277.
PMID: 31850528